Follica, Inc. is developing novel therapies for conditions and disorders of the hair follicle, the epicenter for the development and replenishment of human hair and skin. Treatments for conditions of the follicle account for a total market exceeding $10 billion annually, despite a lack of truly effective solutions.
Current Team (4)Update
Funding Rounds (4) - $24.1MUpdate
They specialize in seed and early-stage investment in novel therapeutics, medical devices, and...
InterWest invests an average of about $7 - 15 million over the span of their involvement with...
Polaris Partners is a venture company investing in digital media, life sciences, and enterprise...
88 East Main Street
Mendham, NJ 07945